Shenkangle相关文献与解析，生知库 | 链接生命科学的每一步

Associations between neutrophil percentage-to-albumin ratio with all-cause and cause-specific mortality among US cancer survivors: evidence from NHANES 2005-2018

美国癌症幸存者中性粒细胞百分比与白蛋白比值与全因死亡率和特定原因死亡率之间的关联：来自 NHANES 2005-2018 年的证据

期刊:Frontiers in Nutrition

影响因子:5.1

doi:10.3389/fnut.2025.1541609

Wang, Mengjia; Wang, Shenkangle; Hu, Jiamiao; Wang, Xuanxuan; Pang, Yuke; Sun, Xiaonan

Efficacy of cyclin-dependent kinase inhibitors with concurrent proton pump inhibitors in patients with breast cancer: a systematic review and meta-analysis

细胞周期蛋白依赖性激酶抑制剂联合质子泵抑制剂治疗乳腺癌患者的疗效：系统评价和荟萃分析

期刊:Oncologist

影响因子:4.2

doi:10.1093/oncolo/oyae320

Guo, Zijie; Zhu, Ziyu; Luo, Mingpeng; Cao, Yijia; Lin, Xixi; Wu, Qingliang; Wang, Shenkangle; Wang, Linbo; Zhou, Jichun

Omitting radiotherapy in LUMINA-like breast cancer after breast conserving surgery: 10-year results of a population-based cohort study

乳腺癌保乳手术后省略放射治疗：一项基于人群队列研究的10年结果

期刊:Oncologist

影响因子:4.2

doi:10.1093/oncolo/oyaf355

Wang, Shenkangle; Zhu, Ziyu; Cui, Binbin; Luo, Mingpeng; Lin, Xixi; Guo, Zijie; Wu, Qingliang; Wang, Linbo; Sun, Xiaonan; Zhou, Jichun

SFRT combined with immunotherapy for a growing hepatocellular carcinoma after the failure of anti-angiogenesis and anti-PD1 treatment: a case report

SFRT联合免疫疗法治疗抗血管生成和抗PD-1治疗失败后进展性肝细胞癌：病例报告

期刊:Frontiers in Oncology

影响因子:3.3

doi:10.3389/fonc.2025.1591424

Hu, Jiamiao; Jin, Yue; Wang, Mengjia; Pang, Yuke; Wang, Shenkangle; Xie, Xuyun; Wang, Zhewen; Sun, Xiaonan

Radiotherapy as a surgical alternative in ductal carcinoma in situ (DCIS): long-term survival benefits and predictors of invasive progression risk

放射疗法作为导管原位癌（DCIS）手术的替代方案：长期生存获益和侵袭性进展风险的预测因素

期刊:Gland Surgery

影响因子:1.6

doi:10.21037/gs-2025-104

Zhu, Ziyu; Guo, Zijie; Wang, Shenkangle; Luo, Mingpeng; Lin, Xixi; Wu, Qingliang; Wang, Linbo; Zhou, Jichun

Identifying risk factors for poor prognosis and developing prognostic model in patients achieving pathological complete response after neoadjuvant therapy for breast cancer

识别乳腺癌新辅助治疗后达到病理完全缓解患者的不良预后风险因素并建立预后模型

期刊:Gland Surgery

影响因子:1.6

doi:10.21037/gs-2025-181

Lin, Xixi; Wang, Shenkangle; Zhu, Ziyu; Guo, Zijie; Luo, Mingpeng; Ding, Qiong; Wang, Linbo; Zhou, Jichun

Tumor microenvironment and immunotherapy for triple-negative breast cancer

肿瘤微环境与三阴性乳腺癌的免疫疗法

期刊:Biomarker Research

影响因子:11.5

doi:10.1186/s40364-024-00714-6

Guo, Zijie; Zhu, Ziyu; Lin, Xixi; Wang, Shenkangle; Wen, Yihong; Wang, Linbo; Zhi, Lili; Zhou, Jichun

Predictive and prognostic biomarkers of bone metastasis in breast cancer: current status and future directions

乳腺癌骨转移的预测和预后生物标志物：现状与未来方向

期刊:Cell and Bioscience

影响因子:6.2

doi:10.1186/s13578-023-01171-8

Wang, Shenkangle; Wu, Wenxin; Lin, Xixi; Zhang, Kevin Matthew; Wu, QingLiang; Luo, Mingpeng; Zhou, Jichun

Conception and Concern: A Review of Breast Cancer Risk in Assisted Reproductive Technology

构思与担忧：辅助生殖技术中乳腺癌风险的综述

Associations between neutrophil percentage-to-albumin ratio with all-cause and cause-specific mortality among US cancer survivors: evidence from NHANES 2005-2018

美国癌症幸存者中性粒细胞百分比与白蛋白比值与全因死亡率和特定原因死亡率之间的关联：来自 NHANES 2005-2018 年的证据

Efficacy of cyclin-dependent kinase inhibitors with concurrent proton pump inhibitors in patients with breast cancer: a systematic review and meta-analysis

细胞周期蛋白依赖性激酶抑制剂联合质子泵抑制剂治疗乳腺癌患者的疗效：系统评价和荟萃分析

Omitting radiotherapy in LUMINA-like breast cancer after breast conserving surgery: 10-year results of a population-based cohort study

乳腺癌保乳手术后省略放射治疗：一项基于人群队列研究的10年结果

SFRT combined with immunotherapy for a growing hepatocellular carcinoma after the failure of anti-angiogenesis and anti-PD1 treatment: a case report

SFRT联合免疫疗法治疗抗血管生成和抗PD-1治疗失败后进展性肝细胞癌：病例报告

Radiotherapy as a surgical alternative in ductal carcinoma in situ (DCIS): long-term survival benefits and predictors of invasive progression risk

放射疗法作为导管原位癌（DCIS）手术的替代方案：长期生存获益和侵袭性进展风险的预测因素

Identifying risk factors for poor prognosis and developing prognostic model in patients achieving pathological complete response after neoadjuvant therapy for breast cancer

识别乳腺癌新辅助治疗后达到病理完全缓解患者的不良预后风险因素并建立预后模型

Tumor microenvironment and immunotherapy for triple-negative breast cancer

肿瘤微环境与三阴性乳腺癌的免疫疗法

Predictive and prognostic biomarkers of bone metastasis in breast cancer: current status and future directions

乳腺癌骨转移的预测和预后生物标志物：现状与未来方向